Procaps Group SA News - PROC

Procaps Group Announces New Chairman

Ruben Minski decides to step down as Executive Chairman and José Minski is appointed as new Chairman of the Board Procaps Group, S.A. (NASDAQ:...

Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F

Procaps Group (Nasdaq: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today...

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today...

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today...

Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today...

Procaps Issues Shareholder Letter from New CEO

Procaps Group (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, today issued a...

Procaps Group – Notice to Shareholders

Dear Shareholders, We became aware on Saturday, January 13, 2024, that the online voting instructions related to the upcoming General Meeting of...

Procaps Group Reports Third Quarter 2023 Results

Net Revenues Increased 5% in 9M23 Year-over-Year on a Constant Currency Basis, Driven by 13% RX Growth Procaps Group, S.A. (NASDAQ: PROC...

Statement from the Board of Directors of Procaps Group

Procaps Group (NASDAQ: PROC) ("Procaps"). Having completed the last ordinary meeting of 2023 on December 19th in which Ruben Minski acted as CEO...

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America PR...

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Agreement Combines Procaps Oral Delivery System Technology and Manufacturing with Genomma’s Strategic Marketing and Distribution Footprint...

Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024

Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced today a strategic...

Procaps Group Update on Third Quarter Results

Procaps Group (NASDAQ: PROC) (“Procaps”), a leading integrated LatAm healthcare and pharmaceutical services company, today announced that it is...

Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023

Company to Host Conference Call on Thursday November 16, 2023 at 10:30 a.m. Eastern Time Procaps Group (NASDAQ: PROC) (“Procaps”), a leading...

Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia

Procaps Ranked First Among Companies in the Pharmaceutical Segment in Colombia for the 5th Consecutive Year Procaps Group (NASDAQ: PROC...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Procaps Group SA (PROC)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

PROC News

Procaps Group Announces New Chairman

Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Procaps Issues Shareholder Letter from New CEO

Procaps Group – Notice to Shareholders

Procaps Group Reports Third Quarter 2023 Results

Statement from the Board of Directors of Procaps Group

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024

Procaps Group Update on Third Quarter Results

Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023

Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia

PROC Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Procaps Group SA (PROC) News

Procaps Group SA (PROC)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

PROC News

Procaps Group Announces New Chairman

Procaps Group Receives Nasdaq Notice Related to Late Filing of its Form 20-F

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Group Delays Filing of Annual Report on Form 20-F

Procaps Announces Formation of Strategic Committee to Explore Value Creation Alternatives

Procaps Issues Shareholder Letter from New CEO

Procaps Group – Notice to Shareholders

Procaps Group Reports Third Quarter 2023 Results

Statement from the Board of Directors of Procaps Group

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Procaps Group and Genomma Lab Announce a Strategic Agreement to Manufacture and Market Softgel Products in Latin America

Procaps Group Announces Appointment of Jose Antonio Vieira as Chief Executive Officer Starting 2024

Procaps Group Update on Third Quarter Results

Procaps Group to Report Third Quarter and Nine Months 2023 Results on Tuesday November 14, 2023

Procaps Group Wins First Place in Ranking of Innovative Companies in the Pharma Sector in Colombia

PROC Discussion

Your Recent History